Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 81 of 200 · By data quality, then INN

  1. lindane

    GAMENE

    TOPICAL FDA: approved

  2. linerixibat

    LYNAVOY

    ORAL FDA: approved

  3. liotrix (t4

    EUTHROID-2

    ORAL FDA: approved

  4. lithium carbonate

    LITHICARB Lacuna Pharma Pty Ltd

    ORAL FDA: approved · TGA: approved

  5. lithium citrate

    LITHIUM CITRATE

    ORAL FDA: approved

  6. lixisenatide

    LYXUMIA

    SUBCUTANEOUS FDA: approved · EMA: withdrawn · PMDA: approved

    A10BJ03

  7. lodoxamide tromethamine

    ALOMIDE

    OPHTHALMIC FDA: approved

  8. lofexidine hydrochloride

    LOFEXIDINE HYDROCHLORIDE

    ORAL FDA: approved

  9. lomefloxacin hydrochloride

    MAXAQUIN

    ORAL FDA: approved

  10. lomitapide mesylate

    JUXTAPID

    ORAL FDA: approved

  11. lomustine

    GLEOSTINE

    ORAL FDA: approved

  12. lonafarnib

    ZOKINVY

    ORAL FDA: approved · EMA: approved

  13. lonapegsomatropin-tcgd

    SKYTROFA

    INJECTION FDA: approved

  14. lopinavir

    KALETRA

    ORAL FDA: approved · EMA: approved

    J05AR10

  15. loracarbef

    LORABID

    ORAL FDA: approved

  16. lorcaserin hydrochloride

    LORCASERIN HYDROCHLORIDE

    ORAL FDA: approved

  17. lorlatinib

    LORVIQUA Pfizer Australia Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    L01ED05

  18. loxapine

    ADASUVE

    INHALATION FDA: approved · EMA: approved

    N05AH01

  19. lucinactant

    SURFAXIN

    INTRATRACHEAL FDA: approved

  20. luliconazole

    LUZU

    TOPICAL FDA: approved

  21. lumateperone tosylate

    LUMATEPERONE TOSYLATE

    ORAL FDA: approved

  22. luspatercept-aamt

    REBLOZYL

    SUBCUTANEOUS FDA: approved

  23. lusutrombopag

    MULPLEO (PREVIOUSLY LUSUTROMBOPAG SHIONOGI)

    ORAL FDA: approved · EMA: approved · PMDA: approved

    B02BX

  24. lutetium lu 177 dotatate

    LUTATHERA

    INTRAVENOUS FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.